Servier and CTI BioPharma Expands collaboration to commercialize PIXUVRI
Servier and CTI BioPharma Corp. jointly announced that they will expand their existing license and development collaboration agreement for PIXUVRI (pixantrone).
Under the expanded…
Read More...
Read More...